As much as I dislike to hear or see his name or his initials in this board, NP made a lot of people a lot of money. The stock was high for whole 2 years because of him. Blame yourselves for not selling then. Again, the purpose of investing in small bio companies in this stage is obtain approval, partnership or a buyout. At this point, .31 is the same as $2 as long as the lights stay on. All I can say is, management better be working hard on one of those 3. We all know that the hope of getting new retail investors is gone, and management knows that as well, hence the new strategy is to release news/results accompanied by scientifically peer reviewed articles is to mainly attract partnerships/buyouts and that is how it should be. And should have been. Cut dry science. Hard results.